J&J psoriasis drug posts mixed results in trial
Thu, 08 Feb 2007 03:27 PM EST
... NEW YORK (Reuters) - Johnson & Johnson said on Wednesday its new type of treatment for psoriasis was highly effective in a mid-stage trial, but was linked to an increased risk of serious adverse events, including heart attacks. ...
Related Topics
- Clinical Trials
- Psoriasis
- Connective Tissue
- Connective Tissue Disorders
- Adalimumab
- Drug Safety
- Prescription Drugs
- Tarceva
- Treatment
- Treatments
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Etanercept
- Infliximab
- Insulin - Mixed
- Bevacizumab Injection
- Adapalene Topical

Not Signed In -


